马匹人工授精市场－全球产业规模、份额、趋势、机会和预测，按解决方案、马匹类型、配销通路、地区和竞争细分，2020-2030 年

2024 年全球马人工授精市场价值为 6.5806 亿美元，预计到 2030 年将达到 9.2324 亿美元，年复合成长率(CAGR) 为 5.78%。在生殖技术的进步和对基因优良马种日益增长的需求的推动下，这个市场正在经历大幅扩张。马业越来越多地采用人工授精 (AI)，这使得饲养者能够增强遗传多样性并降低疾病传播的风险。赛马、障碍赛和盛装舞步等马术运动的日益普及，进一步刺激了对高性能马匹的需求，从而促进了辅助生殖技术的使用。行业领导者正致力于改进精液保存技术和创新授精方法以提高生育率，从而使养殖农场和兽医诊所更广泛地采用人工智慧。

主要市场驱动因素：

马的遗传性状改良

主要市场挑战：

监理合规：复杂的局面

主要市场趋势：

透过基因组检测进行精准基因选择

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球马人工授精市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依解决方案（设备及耗材、精液（正常精液、性别控制精液）、服务）
  • 依马匹类型（运动/赛马、休閒马、其他）
  • 按配销通路（私人、公共）
  • 按地区
  • 按公司分类（2024）
• 产品市场图
  • 按解决方案
  • 按马类型
  • 按配销通路
  • 按地区

第六章：北美马人工授精市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲马人工授精市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙

第八章：亚太马匹人工授精市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国

第九章：南美马人工授精市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲马匹人工授精市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• IMV Technologies SADIR
• Stallion AI Services Ltd
• Zoetis Inc
• Neogen Corp
• Zerlotti Genetics Ltd
• Erc Sro
• CVS UK Ltd
• HOFFMAN AI BREEDERS INC.
• Continental Genetics, LLC
• Minitub GmbH

第 15 章：策略建议

第16章调查会社について・免责事项

Global Equine Artificial Insemination Market was valued at USD 658.06 million in 2024 and is projected to reach USD 923.24 million by 2030, growing at a compound annual growth rate (CAGR) of 5.78%. This market is experiencing substantial expansion, driven by advancements in reproductive technologies and a growing demand for genetically superior horse breeds. The increasing adoption of artificial insemination (AI) within the equine industry has enabled breeders to enhance genetic diversity and mitigate the risk of disease transmission. The rising popularity of equestrian sports, such as racing, show jumping, and dressage, is further fueling the demand for high-performance horses, thus encouraging the use of assisted reproductive technologies. Industry leaders are focusing on improving semen preservation techniques and innovating insemination methods to enhance fertility rates, resulting in broader adoption of AI across breeding farms and veterinary clinics.

Key Market Drivers:

Genetic Improvement in Equine Traits

The equine breeding industry is undergoing a significant shift, driven by the pursuit of superior genetic traits in horses. This quest for genetic excellence has accelerated the growth of the Global Equine Artificial Insemination (AI) Market as breeders increasingly rely on advanced reproductive technologies to improve and refine the genetic composition of their horses. Artificial insemination offers several advantages over traditional mating methods, including access to genetic material from top sires worldwide, which breaks geographical barriers and diversifies the gene pool. This technology allows breeders to selectively pair stallions with desirable traits-such as speed, endurance, agility, and temperament-to produce offspring suited for various disciplines like racing, show jumping, dressage, and workhorse functions.

Additionally, AI helps preserve genetic diversity within equine populations, minimizing the risks associated with inbreeding by introducing fresh genetic material. The technology also accelerates genetic progress by enabling the production of multiple offspring from a single stallion in one breeding season, thus enhancing the breed's overall quality and performance. The demand for high-quality, genetically superior horses is rising, fueled by competitive sports, leisure riding, and other equine-related activities. As breeders aim to meet these market demands, artificial insemination has become a vital tool in achieving their goals. For instance, the equine industry in the United Kingdom plays a significant role in the economy, with substantial spending on breeding, training, and recreational activities. The Department for Environment, Food & Rural Affairs (DEFRA) regulates equine semen collection and storage, ensuring compliance with rigorous standards to safeguard the health and quality of the equine population.

Key Market Challenges:

Regulatory Compliance: A Complex Landscape

A primary challenge in the equine artificial insemination market is navigating the complex and varied regulatory landscape across different countries and regions. Each jurisdiction has its own set of rules governing equine breeding practices, including the use of artificial insemination. Ensuring compliance with these regulations can be a challenging task, particularly for breeders engaged in international trade. Understanding and adhering to these regulatory requirements is crucial to ensuring the legality and acceptance of artificially inseminated horses in various markets.

Key Market Trends:

Precision Genetic Selection through Genomic Testing

The trend toward precision breeding is gaining traction within the equine industry. Genomic testing, which analyzes an individual horse's DNA to assess its genetic potential, is becoming more accessible and cost-effective. This technology allows breeders to make informed decisions about stallion and mare pairings, optimizing the likelihood of producing offspring with desirable traits. As genomic testing becomes more widely adopted, it is expected to lead to even more selective breeding practices, fostering the creation of superior equine bloodlines.

Key Market Players

• IMV Technologies SADIR
• Stallion A I Services Ltd
• Zoetis Inc
• Neogen Corp
• Zerlotti Genetics Ltd
• Erc S.r.o.
• CVS UK Ltd
• HOFFMAN A.I. BREEDERS INC.
• Continental Genetics, LLC
• Minitub GmbH

Report Scope:

In this report, the Global Equine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Artificial Insemination Market, By Solution:

• Equipment & Consumables
• Semen
  • Normal Semen
  • Sexed Semen
• Services

Equine Artificial Insemination Market, By Equine Type:

• Sports/Racing
• Recreation
• Others

Equine Artificial Insemination Market, By Distribution Channel:

• Private
• Public

Equine Artificial Insemination Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Artificial Insemination Market.

Available Customizations:

Global Equine Artificial Insemination market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Artificial Insemination Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 5.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 5.2.3. By Distribution Channel (Private, Public)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Solution
  • 5.3.2. By Equine Type
  • 5.3.3. By Distribution Channel
  • 5.3.4. By Region

6. North America Equine Artificial Insemination Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 6.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 6.2.3. By Distribution Channel (Private, Public)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Equine Artificial Insemination Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Solution
      • 6.3.1.2.2. By Equine Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Equine Artificial Insemination Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Solution
      • 6.3.2.2.2. By Equine Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Equine Artificial Insemination Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Solution
      • 6.3.3.2.2. By Equine Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Equine Artificial Insemination Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 7.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 7.2.3. By Distribution Channel (Private, Public)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Equine Artificial Insemination Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Solution
      • 7.3.1.2.2. By Equine Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Equine Artificial Insemination Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Solution
      • 7.3.2.2.2. By Equine Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. France Equine Artificial Insemination Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Solution
      • 7.3.3.2.2. By Equine Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Equine Artificial Insemination Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Solution
      • 7.3.4.2.2. By Equine Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Equine Artificial Insemination Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Solution
      • 7.3.5.2.2. By Equine Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Equine Artificial Insemination Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 8.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 8.2.3. By Distribution Channel (Private, Public)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Equine Artificial Insemination Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Solution
      • 8.3.1.2.2. By Equine Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. Japan Equine Artificial Insemination Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Solution
      • 8.3.2.2.2. By Equine Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. India Equine Artificial Insemination Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Solution
      • 8.3.3.2.2. By Equine Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. Australia Equine Artificial Insemination Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Solution
      • 8.3.4.2.2. By Equine Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. South Korea Equine Artificial Insemination Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Solution
      • 8.3.5.2.2. By Equine Type
      • 8.3.5.2.3. By Distribution Channel

9. South America Equine Artificial Insemination Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 9.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 9.2.3. By Distribution Channel (Private, Public)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Equine Artificial Insemination Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Solution
      • 9.3.1.2.2. By Equine Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Equine Artificial Insemination Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Solution
      • 9.3.2.2.2. By Equine Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Equine Artificial Insemination Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Solution
      • 9.3.3.2.2. By Equine Type
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Equine Artificial Insemination Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 10.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 10.2.3. By Distribution Channel (Private, Public)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Equine Artificial Insemination Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Solution
      • 10.3.1.2.2. By Equine Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Equine Artificial Insemination Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Solution
      • 10.3.2.2.2. By Equine Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Equine Artificial Insemination Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Solution
      • 10.3.3.2.2. By Equine Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. IMV Technologies SADIR
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Stallion A I Services Ltd
• 14.3. Zoetis Inc
• 14.4. Neogen Corp
• 14.5. Zerlotti Genetics Ltd
• 14.6. Erc S.r.o.
• 14.7. CVS UK Ltd
• 14.8. HOFFMAN A.I. BREEDERS INC.
• 14.9. Continental Genetics, LLC
• 14.10. Minitub GmbH

15. Strategic Recommendations

16. About Us & Disclaimer